KELLY BUMGARNER: Open Payments
NPI 1548714728 · JACKSONVILLE BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,467 in 117 payments from 22 companies in 2025. Trend: 2023 $1,142 · 2024 $2,146 · 2025 $2,467
Food & beverage: $2,467
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $301 |
| SCPHARMACEUTICALS INC. | 11 | $253 |
| Novartis Pharmaceuticals Corporation | 13 | $231 |
| Amgen Inc. | 21 | $207 |
| Novo Nordisk Inc | 10 | $205 |
| AstraZeneca Pharmaceuticals LP | 4 | $180 |
| PFIZER INC. | 9 | $157 |
| ABIOMED | 5 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $133 |
| Alnylam Pharmaceuticals Inc. | 5 | $127 |
Products named: FUROSCIX, REPATHA, Wegovy, LEQVIO, TRICLIP, Kerendia, AMVUTTRA, FARXIGA.
Industry payments across FL — which companies pay providers there.
